Nutra Pharma study shows cobra venom reduces pain

By Elaine Rigoli

Tampa, Fla., Aug. 21 - Nutra Pharma Corp. said Monday that its subsidiary, ReceptoPharm, has published positive results from a recent study on the use of cobratoxin for the relief of pain.

ReceptoPharm is studying the effectiveness of cobra venom and cobratoxin as treatments for multiple sclerosis, HIV, adrenomyeloneuropathy and rabies.

"There are many historical reports of venoms being used in association with pain relief. The purpose of this study was to examine the pain-relieving effects of cobratoxin on laboratory mice. The results suggest that cobratoxin is effective in the relief of pain and might actually be a useful substitute for morphine," ReceptoPharm chief executive officer Paul Reid said in a news release.

Nutra Pharma is a biopharmaceutical company located in Boca Raton, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.